AWA
DTIL icon

Authentikos Wealth Advisory’s Precision BioSciences DTIL Stock Holding History

Authentikos Wealth Advisory’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$43 – 190
2023
Q3 		$43 Buy
+4
New +$61 ﹤0.01% 642

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Authentikos Wealth Advisory's DTIL Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 4 shares — an estimated $43 sold.

Authentikos Wealth Advisory first reported a position in DTIL in Q3 2023 and held it in 1 quarter. The position peaked at $43 in Q3 2023. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 4 Precision BioSciences shares in Q4 2023, an estimated $43.
  • Authentikos Wealth Advisory first reported a position in Precision BioSciences in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's Precision BioSciences position peaked at $43 in Q3 2023.
  • 65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.